Author Search Results

Sima Lev

Sima Lev () is an Israeli biologist and the Joyce and Ben B. Eisenberg Professorial Chair of Molecular Cell Biology at the Weizmann Institute of Science. She looks to uncover the mechanisms that drive the development of triple-negative breast cancer, and to identify new therapeutic strategies. She has discovered several novel human genes including PYK2, Nir1, Nir2, and Nir3. Provided by Wikipedia

1

Lipid Transfer Proteins and Membrane Contact Sites in Human Cancer

by Diego Peretti, SoHui Kim, Roberta Tufi, Sima Lev
Published 2020-01-01

Get full text

Article
2

Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.

by Sung-Young Shin, Anna-Katharina Müller, Nandini Verma, Sima Lev, Lan K Nguyen
Published 2018-06-01

Get full text

Article
3

VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity.

by Meghana Rao, Wenqiang Song, Aixiang Jiang, Yu Shyr, Sima Lev, David Greenstein, Dana Brantley-Sieders, Jin Chen
Published 2012-01-01

Get full text

Article
4

MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells

by Jingyi Yu, Rong Lei, Xueqian Zhuang, Xiaoxun Li, Gang Li, Sima Lev, Miguel F. Segura, Xue Zhang, Guohong Hu
Published 2016-12-01

Get full text

Article
5

Modeling Heterogeneity of Triple‐Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance

by Fabienne Lamballe, Fahmida Ahmad, Yaron Vinik, Olivier Castellanet, Fabrice Daian, Anna‐Katharina Müller, Ulrike A. Köhler, Anne‐Laure Bailly, Emmanuelle Josselin, Rémy Castellano, Christelle Cayrou, Emmanuelle Charafe‐Jauffret, Gordon B. Mills, Vincent Géli, Jean‐Paul Borg, Sima Lev, Flavio Maina
Published 2021-02-01

Get full text

Article